We advise Babraham Research Campus

Dutch property investor and developer Kadans Science Partner has taken its first step into the Cambridge and UK life science market by acquiring a major building on the Babraham Research Campus from Imperial College ThinkSpace.

It has paid an unspecified amount for the B900 building, planting its first Cambridge flag into a Pan-European science park map. ThinkSpace acquired the B900 site in 2015, developed, leased and operated the 49,000 sq ft building until the sale.

The fully let property accommodates two globally powerful life science companies – Abzena and Bicycle Therapeutics – respectively active in the field of cancer and immunology therapeutics.

Kadans existing science partner network includes tenants such as Genmab, Merus and MDxHealth.

Kadans says that both the recently developed, high quality biotech and chemistry laboratory facility as well as BRC as a location are valuable additions to its portfolio.  It says the acquisition price will remain undisclosed.

Babraham Research Campus is an internationally renowned life science cluster in its own right with over 60 companies co-located with the Babraham Institute providing shared facilities and supporting programmes. 

Kadans aims to further build on the strengths of the campus, in conjunction with Babraham Bioscience Technologies to deliver international connectivity, technical design capabilities, operating experience and capital to the mix. 

Kadans’ portfolio comprises 20 properties across nine campus locations, serving more than 230 tenants. Currently two new science park locations and five buildings are being developed and will be added to the portfolio after completion. 

Besides the property acquisition, Kadans aspires to partner with universities and organisations across the UK and beyond to build a strong knowledge-sharing ecosystem of science parks and we are working with them to secure a number of opportunities in leading UK R&D locations.  Our unrivalled knowledge of the UK R&D real estate market and contacts developed over more than 10 years working across the UK is enabling Kadans to scale up UK activity.